- Home
- OUT vs VKTX Comparison
OUT vs VKTX Comparison
Compare OUT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- VKTX
- Stock Information
- Founded
- OUT 2013
- VKTX 2012
- Country
- OUT United States
- VKTX United States
- Employees
- OUT N/A
- VKTX N/A
- Industry
- OUT Real Estate Investment Trusts
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- OUT Real Estate
- VKTX Health Care
- Exchange
- OUT Nasdaq
- VKTX Nasdaq
- Market Cap
- OUT 3.2B
- VKTX 3.0B
- IPO Year
- OUT N/A
- VKTX 2015
- Fundamental
- Price
- OUT $17.88
- VKTX $31.46
- Analyst Decision
- OUT Buy
- VKTX Strong Buy
- Analyst Count
- OUT 7
- VKTX 12
- Target Price
- OUT $19.44
- VKTX $86.42
- AVG Volume (30 Days)
- OUT 1.4M
- VKTX 5.2M
- Earning Date
- OUT 11-11-2025
- VKTX 10-22-2025
- Dividend Yield
- OUT 6.61%
- VKTX N/A
- EPS Growth
- OUT N/A
- VKTX N/A
- EPS
- OUT 0.60
- VKTX N/A
- Revenue
- OUT $1,796,000,000.00
- VKTX N/A
- Revenue This Year
- OUT N/A
- VKTX N/A
- Revenue Next Year
- OUT $2.79
- VKTX N/A
- P/E Ratio
- OUT $30.24
- VKTX N/A
- Revenue Growth
- OUT N/A
- VKTX N/A
- 52 Week Low
- OUT $12.95
- VKTX $18.92
- 52 Week High
- OUT $19.98
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- OUT 40.89
- VKTX 64.59
- Support Level
- OUT $17.84
- VKTX $25.04
- Resistance Level
- OUT $18.59
- VKTX $26.96
- Average True Range (ATR)
- OUT 0.42
- VKTX 1.62
- MACD
- OUT -0.09
- VKTX 0.84
- Stochastic Oscillator
- OUT 2.10
- VKTX 91.35
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.